Medanta Board Approves Q1 FY27 Results, Sets Record Date for ₹0.50 Dividend, Expands Guwahati Hospital Plan
Medanta approved Q1 FY27 results and appointed Pradeep Kumar Singh as Chief Digital Officer. The company set August 14, 2026, as the record date for a ₹0.50 per share final dividend. The Guwahati hospital's capacity is increased to 650 beds with an estimated cost of ₹970 crore.
The approval of quarterly results, dividend declaration, key management appointment, and substantial increase in hospital capacity are all material events that are likely to impact investor sentiment and the company's future prospects.
The company reported financial results, approved a dividend, made a key management appointment, and announced a significant expansion of its hospital capacity, all of which are positive developments.
Global Health Limited (Medanta) announced the outcome of its Board Meeting held on July 30, 2026. The Board approved the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. Certified copies of these results, along with limited review reports from statutory auditors M/s Walker Chandiok & Co LLP, were submitted.
The Board also approved the notice for the 22nd Annual General Meeting (AGM) to be held on September 16, 2026, at 12:00 Noon via Video Conferencing/Other Audio Video Means (VC/OAVM).
In preparation for the AGM, the Board fixed Friday, August 14, 2026, as the record date for determining shareholder entitlement to a final dividend of ₹0.50 per equity share for the financial year 2025-26, subject to shareholder approval at the AGM.
Furthermore, the company announced the appointment of Mr. Pradeep Kumar Singh as Chief Digital Officer, a Senior Management Personnel (SMP), effective July 30, 2026. Mr. Singh brings over 25 years of experience in technology leadership and digital transformation.
The Board also revised the construction plan for the upcoming hospital in Guwahati, increasing the proposed bed capacity from 400 to 650 beds. The estimated project cost is ₹970 crore, to be funded through internal accruals and debt. This expansion aims to strengthen healthcare infrastructure in the North East region and is expected to be completed over the next 3-4 years.
The trading window will reopen 48 hours after the declaration of the financial results.
What to do with a filing like this
Global Health Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Global Health Limited. Read the original for the full detail.